litlas
Log inCreate account

Alan S. Coates

Active 1983–2023

117
Papers
41,962
Citations
95
h-index
117
i10-index

Citations

Citations per year for Alan S. Coates1974: 3 citations1980: 1 citations1981: 1 citations1983: 1 citations1984: 2 citations1985: 6 citations1986: 3 citations1987: 5 citations1988: 6 citations1989: 9 citations1990: 15 citations1991: 17 citations1992: 28 citations1993: 24 citations1994: 21 citations1995: 29 citations1996: 27 citations1997: 51 citations1998: 28 citations1999: 55 citations2000: 79 citations2001: 97 citations2002: 123 citations2003: 163 citations2004: 186 citations2005: 208 citations2006: 212 citations2007: 277 citations2008: 279 citations2009: 280 citations2010: 271 citations2011: 291 citations2012: 266 citations2013: 314 citations2014: 278 citations2015: 306 citations2016: 335 citations2017: 294 citations2018: 260 citations2019: 1,014 citations2020: 1,078 citations2021: 896 citations2022: 740 citations2023: 499 citations2024: 796 citations2025: 336 citations2026: 9 citations1975–1979: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,785 citing papers, 21.7% of this breakdownChina: 1,082 citing papers, 8.4% of this breakdownItaly: 888 citing papers, 6.9% of this breakdownUnited Kingdom: 837 citing papers, 6.5% of this breakdownGermany: 672 citing papers, 5.2% of this breakdownCanada: 462 citing papers, 3.6% of this breakdownAustralia: 449 citing papers, 3.5% of this breakdownFrance: 441 citing papers, 3.4% of this breakdownSwitzerland: 419 citing papers, 3.3% of this breakdownNetherlands: 396 citing papers, 3.1% of this breakdownBelgium: 338 citing papers, 2.6% of this breakdownJapan: 326 citing papers, 2.5% of this breakdown
0%21.7%Other 29.3%

Institutions

Fields

  • Medicine46.6%
  • Biochemistry, Genetics and Molecular Biology44.5%
  • Computer Science1.8%
  • Immunology and Microbiology1.5%
  • Economics, Econometrics and Finance0.9%
  • Engineering0.9%
  • Other3.8%

Topics

  • Breast Cancer Treatment Studies13.5%
  • Breast Lesions and Carcinomas5%
  • HER2/EGFR in Cancer Research4.4%
  • Estrogen and related hormone effects4%
  • Advanced Breast Cancer Therapies3.2%
  • Cancer Risks and Factors2.4%
  • Other67.5%

Coauthors

All papers

Open in search
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    Authors: Aron Goldhirsch, Eric P. Winer, Alan S. Coates, Richard D. Gelber, Martine Piccart, Beat Thürlimann, Hans-Jörg Senn, Kathy S. Albain, Fabrice André, Jonas Bergh, Hervé Bonnefoi, Denisse Bretel-Morales, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Alberto Costa, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Paul E. Goss, Jay R. Harris, Daniel F. Hayes, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 cited by 3,715

  2. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

    Authors: Aron Goldhirsch, W. C. Wood, Alan S. Coates, Richard D. Gelber, Beat Thürlimann, Hans-Jörg Senn - Annals of Oncology 2011 cited by 3,881

  3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    Authors: Alan S. Coates, Eric P. Winer, Aron Goldhirsch, Richard D. Gelber, Michael Gnant, Martine Piccart, Beat Thürlimann, H.-J. Senn, Fabrice André, José Baselga, Jonas Bergh, Hervé Bonnefoi, Harold J. Burstein, Fátima Cardoso, Monica Castiglione‐Gertsch, Alan S. Coates, Marco Colleoni, Giuseppe Curigliano, Nancy E. Davidson, Angelo Di Leo, Bent Ejlertsen, John Forbes, Viviana Galimberti, Richard D. Gelber, Michael Gnant, Aron Goldhirsch, Pamela J. Goodwin, Nadia Harbeck, Daniel F. Hayes, Jens Huober, Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 cited by 1,837

  5. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    Authors: Marco Colleoni, Zhuoxin Sun, Karen N. Price, Per Karlsson, John Forbes, Beat Thürlimann, Lorenzo Gianni, Monica Castiglione, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2016 cited by 623

  6. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    Authors: Sherene Loi, Anita Giobbie‐Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jérusalem, Rupert Bartsch, Manuela Rabaglio, Roswitha Kammler, Rudolf Maibach, Mark J. Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M. Regan, Fabrice André, Debora Fumagalli, Richard D. Gelber, Theodora Goulioti, Anita Hiltbrunner, Rita L. Hui, Heidi Roschitzki, Barbara Ruepp, Frances M. Boyle, Rolf A. Stahel, Stefan Aebi, Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier - The Lancet Oncology 2019 cited by 477

  7. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    Authors: Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Mattia Intra, Giovanni Mazzarol, Samuele Massarut, Janez Žgajnar, Mario Taffurelli, David R. G. Littlejohn, Michael Knauer, Carlo Tondini, Angelo Di Leo, Marco Colleoni, Meredith M. Regan, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Frances M. Boyle, Guy Jérusalem, Rolf A. Stahel, Stefan Aebi, Michael J. Green, Per Karlsson, Ingrid Kössler, István Láng, Anita Hiltbrunner, Jürg Bernhard, Stamatina Fournarakou, Roswitha Kammler, Rudolf Maibach, Manuela Rabaglio, Karin Ribi, Heidi Roschitzki, Susanne Roux, Barbara Ruepp, Caitlin Mahoney, Karen N. Price, L. J. Blacher, Tara Scolese, Karolyn Scott, Sandra Lippert, Theresa Julia Zielinski, Mauro G. Mastropasqua, Stefania Andrighetto, Patrizia Dell’Orto, Giuseppe Renne, Giancarlo Pruneri, Silvia Dellapasqua, Monica Iorfida, Giuseppe Cancello, Emilia Montagna, Anna Cardillo, G. Peruzzotti, R. Ghisini, Alberto Luini, Umberto Veronesi, Mattia Intra, Oreste ­Gentilini, Stefano Zurrida, Giuseppe Curigliano, Franco Nolè, Roberto Orecchia, Marisa Cristina Leonardi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Diana Crivellari, Sandro Morassut, Mario Mileto, Erica Piccoli, Andreas Veronesi, Marisa Donatella Magri, Angelo Buonadonna, Ezio Candiani, Antonino Carbone, Tiziana Perin, Rachele Volpe, Mario Roncadin, Mauro Arcicasa, Francesco Coran, Manuela Lagrassa, A. Recalcati, Maria Emanuela Limonta, Paolo Tricomi, P. Fenaroli, Elisabetta Candiago, Laura Cattaneo, Alberto Gianatti, Donatella Santini, Sylvie Maweja, Philippe Delvenne, Andrée Rorive, Joëlle Collignon, Jean-Rémi Garbay, Marie‐Christine Mathieu, Hanne Galatius, J Hoffmann, Peer Schousen and 102 more - The Lancet Oncology 2018 cited by 565

  8. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    Authors: Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Eva Ciruelos, Harold J. Burstein, Hervé Bonnefoi, Meritxell Bellet, Silvana Martino, Charles E. Geyer, Matthew P. Goetz, Vered Stearns, Graziella Pinotti, Fabio Puglisi, Simon Spazzapan, Miguel Ángel Climent, Lorenzo Pavesi, Thomas Ruhstaller, Nancy E. Davidson, Robert L. Coleman, Marc Debled, Stefan Buchholz, James N. Ingle, Eric P. Winer, Rudolf Maibach, Manuela Rabaglio, Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 cited by 673

  9. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    Authors: Olivia Pagani, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Matthew P. Goetz, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Claudio Chini, Fabio Puglisi, Simon Spazzapan, Thomas Ruhstaller, Eric P. Winer, Barbara Ruepp, Sherene Loi, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan, Prudence A. Francis - Journal of Clinical Oncology 2022 cited by 154

  10. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    Authors: Viviana Galimberti, Bernard F. Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra, Oreste ­Gentilini, Mauro G. Mastropasqua, Giovanni Mazzarol, Samuele Massarut, Jean‐Remi Garbay, Janez Žgajnar, Hanne Galatius, A. Recalcati, David R. G. Littlejohn, Monika Bamert, Marco Colleoni, Karen N. Price, Meredith M. Regan, Aron Goldhirsch, Alan S. Coates, Richard D. Gelber, Umberto Veronesi - The Lancet Oncology 2013 cited by 1,229

  11. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    Authors: Olivia Pagani, Meredith M. Regan, Barbara Walley, Gini F. Fleming, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Harold J. Burstein, Edith A. Perez, Eva Ciruelos, Vered Stearns, Hervé Bonnefoi, Silvana Martino, Charles E. Geyer, Graziella Pinotti, Fabio Puglisi, Diana Crivellari, Thomas Ruhstaller, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Jürg Bernhard, Weixiu Luo, Karin Ribi, Giuseppe Viale, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 cited by 747

  12. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    Authors: Prudence A. Francis, Meredith M. Regan, Gini F. Fleming, István Láng, Eva Ciruelos, Meritxell Bellet, Hervé Bonnefoi, Miguel Ángel Climent, Gian Antonio Da Prada, Harold J. Burstein, Silvana Martino, Nancy E. Davidson, Charles E. Geyer, Barbara Walley, Robert E. Coleman, Pierre Kerbrat, Stefan Buchholz, James N. Ingle, Eric P. Winer, Manuela Rabaglio, Rudolf Maibach, Barbara Ruepp, Anita Giobbie‐Hurder, Karen N. Price, Marco Colleoni, Giuseppe Viale, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber - New England Journal of Medicine 2014 cited by 727

  13. Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

    Authors: Otto Metzger, Zhuoxin Sun, Giuseppe Viale, Karen N. Price, Diana Crivellari, Raymond Snyder, Richard D. Gelber, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch, Fátima Cardoso - Journal of Clinical Oncology 2013 cited by 343

  14. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    Authors: Bernhard C. Pestalozzi, David Zahrieh, Elizabeth Mallon, Barry A. Gusterson, Karen N. Price, Richard D. Gelber, Stig B. Holmberg, Jurij Lindtner, Raymond Snyder, Beat Thürlimann, Elizabeth Murray, Giuseppe Viale, Monica Castiglione‐Gertsch, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2008 cited by 497

  15. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    Authors: Olivia Pagani, Prudence A. Francis, Gini F. Fleming, Barbara Walley, Giuseppe Viale, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Graziella Pinotti, Angelo Di Leo, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, Meredith M. Regan, for the SOFT and TEXT Investigators and International Breast Cancer Study Group - Journal of Clinical Oncology 2019 cited by 150

  16. Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

    Authors: Jacquie Chirgwin, Anita Giobbie‐Hurder, Alan S. Coates, Karen N. Price, Bent Ejlertsen, Marc Debled, Richard D. Gelber, Aron Goldhirsch, Ian Smith, Manuela Rabaglio, John Forbes, Patrick Neven, István Láng, Marco Colleoni, Beat Thürlimann - Journal of Clinical Oncology 2016 cited by 253

  17. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    Authors: Prudence A. Francis, Gini F. Fleming, István Láng, Eva Ciruelos, Hervé Bonnefoi, Meritxell Bellet, Antônio Bernardo, Miguel Ángel Climent, Silvana Martino, Begoña Bermejo, Harold J. Burstein, Nancy E. Davidson, Charles E. Geyer, Barbara Walley, James N. Ingle, Robert E. Coleman, Bettina Müller, Fanny Le Du, Sibylle Loibl, Eric P. Winer, Barbara Ruepp, Sherene Loi, Marco Colleoni, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - Journal of Clinical Oncology 2022 cited by 58

  18. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

    Authors: Poornima Saha, Meredith M. Regan, Olivia Pagani, Prudence A. Francis, Barbara Walley, Karin Ribi, Jürg Bernhard, Weixiu Luo, Henry Gómez, Harold J. Burstein, Vani Parmar, Roberto Torres, Josephine Stewart, Meritxell Bellet, Antonia Perelló, Faysal Dane, António Moreira, Daniel Vorobiof, Michelle Nottage, Karen N. Price, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber, Marco Colleoni, Gini F. Fleming, for the SOFT, TEXT Investigators, the International Breast Cancer Study Group - Journal of Clinical Oncology 2017 cited by 148

  19. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    Authors: Mitch Dowsett, Jack Cuzick, J. N. Ingle, Alan S. Coates, John Forbes, Judith M. Bliss, Marc Buyse, Michael Baum, Aman U. Buzdar, Marco Colleoni, R. Charles Coombes, Claire Snowdon, Michael Gnant, R. Jakesz, Manfred Kaufmann, Francesco Boccardo, Jon Godwin, Christina Davies, Richárd Pető - Journal of Clinical Oncology 2009 cited by 815

  20. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

    Authors: Jürg Bernhard, Weixiu Luo, Karin Ribi, Marco Colleoni, Harold J. Burstein, Carlo Tondini, Graziella Pinotti, Simon Spazzapan, Thomas Ruhstaller, Fabio Puglisi, Lorenzo Pavesi, Vani Parmar, Meredith M. Regan, Olivia Pagani, Gini F. Fleming, Prudence A. Francis, Karen N. Price, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Barbara Walley - The Lancet Oncology 2015 cited by 179

  21. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

    Authors: Bernhard C. Pestalozzi, David Zahrieh, Karen N. Price, Stig B. Holmberg, Jurij Lindtner, John P. Collins, Diana Crivellari, Martin F. Fey, Elizabeth Murray, Olivia Pagani, Edda Simoncini, Monica Castiglione‐Gertsch, Richard D. Gelber, Alan S. Coates, Aron Goldhirsch - Annals of Oncology 2006 cited by 412

  22. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

    Authors: Otto Metzger, Anita Giobbie‐Hurder, Elizabeth Mallon, Barry A. Gusterson, Giuseppe Viale, Eric P. Winer, Beat Thürlimann, Richard D. Gelber, Marco Colleoni, Bent Ejlertsen, Marc Debled, Karen N. Price, Meredith M. Regan, Alan S. Coates, Aron Goldhirsch - Journal of Clinical Oncology 2015 cited by 199

  23. Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials

    Authors: Meredith M. Regan, Prudence A. Francis, Olivia Pagani, Gini F. Fleming, Barbara Walley, Giuseppe Viale, Marco Colleoni, István Láng, Henry Gómez, Carlo Tondini, Graziella Pinotti, Karen N. Price, Alan S. Coates, Aron Goldhirsch, Richard D. Gelber - Journal of Clinical Oncology 2016 cited by 182

  24. Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

    Authors: Marianne Ewertz, Kathryn P. Gray, Meredith M. Regan, Bent Ejlertsen, Karen N. Price, Beat Thürlimann, Hervé Bonnefoi, John Forbes, Robert Paridaens, Manuela Rabaglio, Richard D. Gelber, Marco Colleoni, István Láng, Ian E. Smith, Alan S. Coates, Aron Goldhirsch, Henning T. Mouridsen - Journal of Clinical Oncology 2012 cited by 133